Pith. sign in

REVIEW 2 major objections 6 minor 57 references

Inheritance of intracellular viral RNA in a multiscale model of hepatitis C infection

T0 review · 2 major / 6 minor · reviewed 2026-08-07 · deepseek-v4-flash

Pith's one-line read A multiscale model of hepatitis C shows that infected-cell proliferation can make infection persist even when the basic reproductive number is below one, and reduces exactly to an ODE system whose bifurcation analysis reveals bistability.

desk verdict Solid multiscale ODE reduction and bifurcation analysis, but the generational-tracking equivalence in Sec 3.2 is invalid as written because Eq (11) drops the vRNA transfer terms; the conclusion still survives correction. read the letter →

arxiv 2506.00939 v1 pith:2MISPQBD submitted 2025-06-01 q-bio.PE

classification q-bio.PE MSC 92D3034C2335Q92
keywords hepatitisCvirusmultiscaleviraldynamicsage-structuredPDEinfectedcellproliferationRNAinheritancebasicreproductionnumberbackwardsbifurcationsaddle-nodetranscritical
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

This paper shows how to include proliferation of infected hepatocytes in a multiscale model of hepatitis C without breaking the bookkeeping of intracellular viral RNA. The authors construct a structured PDE model in which cells born of division inherit, on average, half the mother cell's vRNA, and prove that this infinite-dimensional model is exactly equivalent to a four-variable ODE system when the intracellular rates are constant. They also prove that an infinite system tracking each generation of divisions collapses to the same ODEs. The bifurcation analysis then shows that if infected hepatocytes divide faster than uninfected ones, the infection can persist even when the basic reproductive number $R$ is below one, because the uninfected equilibrium undergoes a backward transcritical bifurcation and bistability appears.

What carries the argument

The central mechanism is writing proliferation as a boundary condition rather than a source term. Infected cells are split into newly infected cells, entering at age zero with $\zeta$ copies of vRNA, and cells born of proliferation, which enter at age zero with half the average vRNA of all proliferating mother cells. Differentiating the total vRNA integral $R(t)=\int_0^\infty (r_0 i_0+r_p i_p)\,da$ along characteristics with Leibniz's rule makes the proliferation terms cancel exactly, leaving the same $R$ equation as in the proliferation-free model. For the generation-tracking version, the infinite system of ODEs telescopes when summed, giving the same aggregate equations. The bifurcation analysis then rests on a quadratic equilibrium condition $F(T^*)=0$ whose two roots can collide only when $\eta>1$, yielding the backward transcritical bifurcation and, at a codimension-two point, a saddle-node transcritical bifurcation in which a saddle-node and a transcritical bifurcation coincide.

What would settle it

Simulate the full age-structured model with an age-dependent production or death rate and show that total virus and infected-cell trajectories diverge from the ODE system; any such divergence falsifies the equivalence claim. For the bistability claim, numerically continue the full PDE with $\eta>1$ and check whether a backward transcritical bifurcation at $R=1$ actually appears.

Watch

Extended reading notes

Core claim

The paper claims that a multiscale PDE model of hepatitis C that includes proliferation of infected hepatocytes and the inheritance of intracellular vRNA is mathematically equivalent to the ODE system (10) whenever the rates $\alpha,\mu,\rho$ and $\delta$ are independent of infection age, and that an infinite-generation version collapses to the same equations. Bifurcation analysis of the ODE shows that the uninfected equilibrium $(T_{\max},0,0,0)$ is stable for $R<1$ in the standard forward case, but when infected hepatocytes have a proliferative advantage ($\eta>1$) and $R^\dagger<1$, the transcritical bifurcation at $R=1$ is backward, producing bistability between the uninfected equilibrium and a total-infection equilibrium in which infected cells sustain themselves without new infections. Thus infection can persist even when the basic reproductive number is below one. The paper further identifies a saddle-node transcritical bifurcation that separates the forward and backward regimes and reports that this is the first such bifurcation found in a viral dynamics model with only quadratic nonlinearities.

Load-bearing premise

The reduction to ordinary differential equations assumes that the rates of viral RNA production, degradation, secretion, and infected-cell death are independent of infection age, and that the proliferation hazard is constant over age; if these vary with age, the equivalence and the $R<1$ persistence conclusion do not automatically carry over.

Editorial extensions

If this is right

  • With $\eta>1$ and $R^\dagger<1$, there is a parameter window $R^\dagger<R<1$ where both the uninfected and total-infection equilibria are locally stable, so the outcome depends on initial conditions.
  • The ODE system (10) can be used for parameter estimation and clinical data fitting, exactly as the proliferation-free equivalent ODEs have been.
  • Infinite-generation tracking gives the same total infected cell and vRNA dynamics as the two-cohort model, so the simpler model suffices for aggregate predictions.
  • A direct adaptation of the proliferation-free ODE to include proliferation produces spontaneous intracellular vRNA; the PDE-derived model does not.
  • The saddle-node transcritical bifurcation at $R=R^\dagger$ with $\eta=1+\delta\zeta/\alpha+\alpha\beta\rho T_{\max}/(\gamma(\rho+\mu+\delta)c)$ separates forward from backward bifurcation regimes.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • A testable extension suggested by the conservation argument: apply the same boundary-condition inheritance to other cytoplasmic RNA viruses and check whether standard ODE reductions spuriously create intracellular genomes at division.
  • If the backward bifurcation holds in patients, antiviral therapy that drives $R$ below 1 may still fail to cure when infected hepatocytes have a proliferative advantage; one could experimentally test whether reducing hepatocyte proliferation shrinks the bistable region.
  • The generational equivalence implies that for population-level kinetics, generation-resolved measurements of intracellular vRNA are not needed; such measurements would be useful only to test the average-inheritance assumption itself.
  • The saddle-node transcritical bifurcation structure may be generic to within-host models with logistic growth of infected cells, so similar codimension-two points should be looked for in other infection models with quadratic nonlinearities.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

2 major / 6 minor

Summary. The paper extends the Guedj et al. multiscale PDE model of hepatitis C infection to include proliferation of infected hepatocytes with inheritance of intracellular vRNA. The authors distinguish newly infected cells from proliferation-derived cells, derive a PDE system (Eq. (4)) with boundary conditions encoding vRNA inheritance, and show that, under age-independent intracellular rates and an exponential proliferation hazard, this system is equivalent to the ODE system (Eq. (10)). They then introduce an infinite-generation formulation (Eq. (11)) and argue that tracking generations does not change the total infected-cell and vRNA dynamics. The paper computes the basic reproduction number, analyzes the uninfected, infected, and total-infection equilibria, identifies forward and backward transcritical bifurcations at R=1, and reports a saddle-node transcritical bifurcation, illustrating the results with Matcont and comparing against the model of Elkaranshawy and Ezzat.

Significance. If the technical issues are corrected, this is a useful and broadly sound contribution. The main PDE-to-ODE reduction in Section 3.1 is correct and is derived from first principles, the reproduction number in Eq. (14) is obtained from a characteristic polynomial and matches the local stability condition, and the bifurcation thresholds are given in closed form. The paper also performs a valuable service by demonstrating in Appendix F that a previously published ODE adaptation of the multiscale model spuriously generates intracellular vRNA upon proliferation. The biological message, that a proliferative advantage of infected hepatocytes can create bistability and persistence even when R<1, is clearly supported by the analysis. The main weakness is in Section 3.2, where the derivation of the generation-specific vRNA ODEs is incorrect as written; this affects the claimed proof of equivalence between the generational and non-generational models, although the conclusion appears repairable.

major comments (2)
  1. [Section 3.2, Eq. (11)] The ODEs for R_n(t) in Eq. (11) omit the vRNA transfer terms that arise from proliferation. Differentiating R_n(t)=∫ i_n(t,a)r_n(t,a)da along characteristics gives, for n≥1, dR_n/dt = ηb(t)R_{n-1} + αI_n - (δ+μ+ρ)R_n - ηb(t)R_n, and for n=0, dR_0/dt = ζβV(t)T(t) + αI_0 - (δ+μ+ρ)R_0 - ηb(t)R_0. The terms -ηbR_n and +ηbR_{n-1} represent the removal of vRNA from generation n when cells divide and its appearance in generation n+1; they do not cancel within a single generation. Equation (11) as printed therefore describes a different system in which proliferation neither transfers nor removes intracellular vRNA between generations. This is a load-bearing error because the subsequent telescoping argument is presented as the proof that generational tracking does not affect dynamics. The conclusion can likely be recovered by including the transfer terms and noting that they telescope when summed over n, provided one also shows R_N(t)→0 as N→∞, but the manuscript must be corrected.
  2. [Section 3.2 / Appendix A, Proposition 3.2] Proposition 3.2 and the interchange-of-summation argument are stated for the incorrect system Eq. (11), so they do not currently justify the equivalence claim for the generational model derived from the PDEs. In addition, the proof of Lemma A.2 contains an inconsistency: the expression for I_n(t) in Eq. (23) uses the Erlang density with rate 2ηb(t), while Lemma A.2 writes g_n^1(∫_{t-s}^t 2b(σ)dσ) and then uses ∑_{n=1}^∞ g_n^a(s)=a, which changes the prefactor by a factor of η. Once Eq. (11) is corrected, the existence proof and the summation argument need to be redone; it may be simpler to exploit the triangular structure of the corrected I_n subsystem and to bound R_n by a multiple of I_n when proving R_N→0.
minor comments (6)
  1. [Abstract] The abstract contains the typo 'repoductive number' twice; it should read 'reproductive number'.
  2. [Figure 2 caption] The captions for panels C and D both state η=1.26, but the text in Section 4 says the two panels show η=1.26 and η=1.24, respectively; one caption is incorrect.
  3. [Appendix A, Eq. (23)] The notation for the Erlang density should be harmonized: Eq. (23) and Lemma A.2 use different rate parameters (2ηb versus 2b), and the argument of g_n^1 should be written consistently to make the change of variables transparent.
  4. [Section 3.2] The sentence 'using the same approach as in Section 3' to compute dR_n/dt hides the boundary term at a=0 and the loss term due to proliferation; it would be helpful to show the intermediate step even in the corrected version.
  5. [Section 4, claim of first SNTC bifurcation] The novelty claim that this is the first saddle-node transcritical bifurcation in a viral dynamics model with only quadratic nonlinearities is strong; the authors should either substantiate it with a more systematic literature search or soften the wording.
  6. [References] The text cites Kitagawa et al. as both [28] and [29] for closely related results; the distinction between the PDE-to-ODE paper and the transformed-ODE analysis should be made explicit at the point of citation.

Circularity Check

0 steps flagged · score 0.0 of 10

No circularity found: the ODE reduction (Eq 4 to Eq 9) and the bifurcation analysis are derived from the stated PDE with explicit boundary terms, and the generation-tracking equivalence is an internal consistency check rather than an input/output smuggling.

full rationale

The central derivation in Sec. 3.1 differentiates R(t) directly from the PDEs using Leibniz's rule, explicitly carrying the proliferation boundary terms i_p(t,0)r_p(t,0) and the loss term ∫b h (r0 i0 + rp ip) da; these cancel exactly, yielding dR/dt = ζβVT + αI − (δ+μ+ρ)R. The I equation is obtained by the same direct computation, and the h(a)=η assumption is stated openly. No parameter is fit to a target and then relabeled as a prediction: the reproduction number R and all bifurcation thresholds are closed-form functions of the model parameters, and α=300 is an illustrative calibration used only for the Matcont figures. Self-citations (Cassidy et al. 2019/2021, Belluccini et al. 2022) supply representation tools such as Erlang/linear-chain expansions, but the existence theory for the infinite ODE system is imported from the external McClure-Wong theorem, and no 'uniqueness theorem' from the authors' earlier work is invoked to force the modeling choice. The generation-tracking statement in Sec. 3.2 is a bookkeeping identity: r_n(t,0) is defined as the average mother-cell vRNA, so proliferation transfers cancel in the total R equation; this is a conservation property by construction, not an empirical prediction. Separately from circularity, Eq. (11) as printed omits the boundary and proliferation-loss terms in dR_n/dt (the +ηbR_{n-1} − ηbR_n contributions), so the written telescoping argument is incomplete; however, adding these terms recovers the stated conclusion and does not affect the main ODE reduction or the bifurcation analysis of Eq. (10). This is a correctness concern, not a circularity concern.

Assumptions & free parameters 2 free parameters · 5 assumptions · 0 invented entities

The central claims rest on standard structured-population modeling assumptions: age-independent intracellular rates, constant proliferation hazard, logistic hepatocyte growth, and equal vRNA division. These are stated in the paper and the age-independence is explicitly acknowledged as a limitation. No free parameters are fitted to data in the analytical results; the numerical values in Table 1 are literature inputs, with alpha and gamma chosen for illustration.

free parameters (2)
  • alpha (intracellular vRNA production rate) = 300 copies/cell/day
    Set above literature estimates to make predicted steady-state viral loads consistent with clinical data. The analytical bifurcation results are independent of this value; it only affects the numerical illustration.
  • gamma (hepatocyte net proliferation rate) = 0.2 /day
    Chosen by the authors for the numerical bifurcation analysis; they state qualitative results are robust to this choice.
assumptions (5)
  • domain assumption Intracellular rate constants alpha, mu, rho and infected cell death rate delta are independent of infection age.
    Required for the PDE-ODE equivalence (Section 3.1); the paper acknowledges this in the Discussion and cites age-dependent extensions as future work.
  • domain assumption Probability of infected cell proliferation is age-independent, h(a)=eta constant.
    Needed to close the ODE for I(t) in Eq (8); the authors note other hazard functions are possible via the linear chain trick.
  • domain assumption Hepatocyte population follows logistic growth with common carrying capacity Tmax for uninfected and infected cells.
    Used throughout Section 4 for the bifurcation analysis; standard in the HCV modeling literature the paper cites.
  • domain assumption Daughter cells inherit on average half of the mother cell's vRNA.
    Justified biologically by equal cytoplasmic division; the generational model in Section 3.2 is designed to test this, though the paper's presented infinite system has an error.
  • standard math McClure-Wong existence theorem for infinite systems of ODEs (Theorem A.1).
    Used in Appendix A to prove strong continuity of solutions of the generational infinite system.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Inheritance of intracellular viral RNA in a multiscale model of hepatitis C infection." pith.science (2026). https://pith.science/paper/2MISPQBD

@misc{pith2026250600939,
  author       = {Pith},
  title        = {Pith review of: Inheritance of intracellular viral RNA in a multiscale model of hepatitis C infection},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/2MISPQBD}},
  note         = {Machine review of arXiv:2506.00939}
}
read the original abstract

Multiscale mathematical models of hepatitis C infection have been instrumental in our understanding of direct acting antivirals. These models include the mechanisms driving intracellular viral production and explicitly model the intracellular concentration of viral RNA. Incorporating proliferation of infected hepatocytes in these models can be subtle, as infected daughter cells inherit viral RNA from the proliferating mother cell. In this note, we show how to incorporate this inheritance within a multiscale model of HCV infection. As in typical multiscale models of HCV infection, we show that this model is mathematically equivalent to a system of ordinary differential equations and perform bifurcation analysis of the resulting ODE that demonstrates that proliferation of infected hepatocytes can lead to infection persistence even if the basic repoductive number is less than one.

Figures

Figures reproduced from arXiv: 2506.00939 by the authors.

Figure 1
Figure 1. Schematic of the multiscale model of HCV infection. A) The intracellular HCV life cycle, which begins with infection of a hepatocyte and the release of positive strand vRNA, shown in blue and denoted vRNA(+), into the cell cytoplasm following the uncoating of the HCV viral capsid. This vRNA is translated into viral proteins, such as the RNA-dependent RNA polymerase and other proteins that first copy the positive str… view at source ↗
Figure 2
Figure 2. Numerical bifurcation analysis of Eq. (10) All panels show the fraction of infected hepatocytes at equilibria, I ∗/Tmax with parameters given in [PITH_FULL_IMAGE:figures/full_fig_p016_2.png] view at source ↗
Figure 3
Figure 3. Schematic of the multiscale model of HCV infection with direct acting antiviral treatment. Panel A shows the intracellular HCV life cycle, which begins with infection of a hepatocyte and the release of positive strand vRNA, shown in blue and denoted vRNA(+), into the cell cytoplasm following the uncoating of the HCV viral capsid. This vRNA is translated into viral proteins, such as the RNA-dependent RNA polymerase a… view at source ↗

Discussion (0). Sign in to comment.

Reference graph

Works this paper leans on

57 extracted references · 57 canonical work pages

  1. [1]

    R., Marsh, K

    Aunins, T. R., Marsh, K. A., Subramanya, G., Uprichard, S. L., Perelson, A. S., and Chatterjee, A. (2018). Intracellular Hepatitis C Virus Modeling Predicts Infection Dynamics and Viral Protein Mechanisms.J. Virol., 92:1–21

  2. [2]

    Belluccini, G., López-García, M., Lythe, G., and Molina-París, C. (2022). Counting generations in birth and death processes with competing Erlang and exponential waiting times.Sci. Rep., 12:11289

  3. [3]

    F., Ji, D., Lau, G., Schinazi, R

    Cardozo, E. F., Ji, D., Lau, G., Schinazi, R. F., Chen, G., Ribeiro, R. M., and Perelson, A. S. (2020). Disentangling the lifespans of hepatitis C virus–infected cells and intracellular vRNA replication–complexes during direct–acting anti–viral therapy.J. Viral Hepat., 27:261–269

  4. [4]

    Cassidy, T. (2021). Distributed Delay Differential Equation Representations of Cyclic Differential Equations.SIAM J. Appl. Math., 81:1742–1766

  5. [5]

    Cassidy, T., Craig, M., and Humphries, A. R. (2019). Equivalences between age structured models and state dependent distributed delay differential equations.Math. Biosci. Eng., 16:5419–5450

  6. [6]

    R., Craig, M., and Mackey, M

    Cassidy, T., Humphries, A. R., Craig, M., and Mackey, M. C. (2020). Characterizing Chemotherapy-Induced Neutropenia and Monocytopenia Through Mathematical Modelling.Bull. Math. Biol., 82:104

  7. [7]

    Cassidy, T., Nichol, D., Robertson-Tessi, M., Craig, M., and Anderson, A. R. A. (2021). The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.PLOS Comput. Biol., 17:e1009348

  8. [8]

    Champredon, D., Dushoff, J., and Earn, D. J. D.. (2018) Equivalence of the Erlang-Distributed SEIR Epidemic Model and the Renewal Equation.SIAM J. Appl. Math., 78, pp. 3258–3278

Show all 57 references
  1. [9]

    E., Kallwitz, E., Ribeiro, R

    Dahari, H., Layden-Almer, J. E., Kallwitz, E., Ribeiro, R. M., Cotler, S. J., Layden, T. J., and Perelson, A. S. (2009). A Mathematical Model of Hepatitis C Virus Dynamics in Patients With High Baseline Viral Loads or Advanced Liver Disease. Gastroenterology, 136:1402–1409

  2. [10]

    M., Perelson, A

    Dahari, H., Major, M., Zhang, X., Mihalik, K., Rice, C. M., Perelson, A. S., Feinstone, S. M., and Neumann, A. U. (2005). Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production. Gastroenterology, 128:1056–1066

  3. [11]

    M., and Perelson, A

    Dahari, H., Lo, A., Ribeiro, R. M., and Perelson, A. S. (2007a). Modeling hepatitis C virus dynamics: Liver regeneration and critical drug efficacy.J. Theor. Biol., 247:371–381

  4. [12]

    M., and Perelson, A

    Dahari, H., Ribeiro, R. M., and Perelson, A. S. (2007b). Triphasic decline of hepatitis C virus RNA during antiviral therapy.Hepatology, 46:16–21

  5. [13]

    M., Rice, C

    Dahari, H., Ribeiro, R. M., Rice, C. M., and Perelson, A. S. (2007c). Mathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 Cells.J. Virol., 81:750–760

  6. [14]

    A., Meijer, H

    Dhooge, A., Govaerts, W., Kuznetsov, Y . A., Meijer, H. G., and Sautois, B. (2008). New features of the software MatCont for bifurcation analysis of dynamical systems.Math. Comput. Model. Dyn. Syst., 14:147–175

  7. [15]

    Diekmann, O., Gyllenberg, M., and Metz, J. A. J. (2018). Finite dimensional state representation of linear and nonlinear delay systems.J. Dyn. Differ. Equations, 30:1439–1467

  8. [16]

    Donohue, J. G. and Piiroinen, P. T. (2020). Normal-form analysis of the cusp-transcritical interaction: applications in population dynamics.Nonlinear Dyn., 100:1741–1753

  9. [17]

    Elkaranshawy, H. A. and Ezzat, H. M. (2024). An ODEs multiscale model with cell proliferation for hepatitis C virus infection treated with direct acting antiviral agents.J. Biol. Dyn., 18:1–29

  10. [18]

    Gonçalves, A., Lemenuel-Diot, A., Cosson, V ., Jin, Y ., Feng, S., Bo, Q., and Guedj, J. (2021). What drives the dynamics of HBV RNA during treatment?J. Viral Hepat., 28:383–392

  11. [19]

    E., and Perelson, A

    Goyal, A., Liao, L. E., and Perelson, A. S. (2019). Within-host mathematical models of hepatitis B virus infection: Past, present, and future.Curr. Opin. Syst. Biol., 18:27–35. 19

  12. [20]

    Goyal, A., Ribeiro, R., and Perelson, A. (2017). The Role of Infected Cell Proliferation in the Clearance of Acute HBV Infection in Humans.Viruses, 9:350

  13. [21]

    D., Nettles, R

    Guedj, J., Dahari, H., Rong, L., Sansone, N. D., Nettles, R. E., Cotler, S. J., Layden, T. J., Uprichard, S. L., and Perelson, A. S. (2013). Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-l...

  14. [22]

    and Neumann, A

    Guedj, J. and Neumann, A. (2010). Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.J. Theor. Biol., 267:330–340

  15. [23]

    and Perelson, A

    Guedj, J. and Perelson, A. S. (2011). Second-phase hepatitis C virus RNA decline during telaprevir-based therapy in- creases with drug effectiveness: Implications for treatment duration.Hepatology, 53:1801–1808

  16. [24]

    L., Chayama, K., and Dahari, H

    Hailegiorgis, A., Ishida, Y ., Collier, N., Imamura, M., Shi, Z., Reinharz, V ., Tsuge, M., Barash, D., Hiraga, N., Yokomichi, H., Tateno, C., Ozik, J., Uprichard, S. L., Chayama, K., and Dahari, H. (2023). Modeling suggests that virion produc- tion cycles within individual ce...

  17. [25]

    Iwanami, S., Kitagawa, K., Ohashi, H., Asai, Y ., Shionoya, K., Saso, W., Nishioka, K., Inaba, H., Nakaoka, S., Wakita, T., Diekmann, O., Iwami, S., and Watashi, K. (2020). Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C v...

  18. [26]

    A., Cassidy, T., Ribeiro, R

    Iyaniwura, S. A., Cassidy, T., Ribeiro, R. M., and Perelson, A. S. (2025). A multiscale model of the action of a capsid assembly modulator for the treatment of chronic hepatitis B.PLOS Comput. Biol.,21: e1012322

  19. [27]

    S., Iwamoto, M., Hayashi, S., Park, H., Nishiyama, T., Nakamura, N., Fujita, Y ., Nakaoka, S., Aihara, K., Perelson, A

    Kitagawa, K., Kim, K. S., Iwamoto, M., Hayashi, S., Park, H., Nishiyama, T., Nakamura, N., Fujita, Y ., Nakaoka, S., Aihara, K., Perelson, A. S., Allweiss, L., Dandri, M., Watashi, K., Tanaka, Y ., and Iwami, S. (2024). Multiscale modeling of HBV infection integrating intra- a...

  20. [28]

    Kitagawa, K., Kuniya, T., Nakaoka, S., Asai, Y ., Watashi, K., and Iwami, S. (2019). Mathematical Analysis of a Trans- formed ODE from a PDE Multiscale Model of Hepatitis C Virus Infection.Bull. Math. Biol., 81:1427–1441

  21. [29]

    Kitagawa, K., Nakaoka, S., Asai, Y ., Watashi, K., and Iwami, S. (2018). A PDE multiscale model of hepatitis C virus infection can be transformed to a system of ODEs.J. Theor. Biol., 448:80–85

  22. [30]

    Lau, G., Benhamou, Y ., Chen, G., Li, J., Shao, Q., Ji, D., Li, F., Li, B., Liu, J., Hou, J., Sun, J., Wang, C., Chen, J., Wu, V ., Wong, A., Wong, C. L. P., Tsang, S. T. Y ., Wang, Y ., Bassit, L., Tao, S., Jiang, Y ., Hsiao, H., Ke, R., Perelson, A. S. and Schinazi, R. F. (2...

  23. [31]

    Li, YY ., Yamane, D., Masaki, T., and Lemon, S. M. (2015). The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA.Nat. Rev. Microbiol, 13:544–558

  24. [32]

    C., and Webb, G

    Magal, P., McCluskey, C. C., and Webb, G. F. (2010). Lyapunov functional and global asymptotic stability for an infection- age model.Appl. Anal., 89:1109–1140

  25. [33]

    and Wong, R

    McClure, J. and Wong, R. (1976). Infinite systems of differential equations.Can. J. Math., 28:1132–1145

  26. [34]

    and Diekmann, O

    Metz, J. and Diekmann, O. (1986). The Dynamics of Physiologically Structured Populations. 68:1–528

  27. [35]

    W., Gilchrist, M

    Nelson, P. W., Gilchrist, M. A., Coombs, D., Hyman, J. M., and Perelson, A. S. (2004). An Age-Structured Model of HIV Infection that Allows for Variations in the Production Rate of Viral Particles and the Death Rate of Productively Infected Cells.Math. Biosci. Eng., 1:267–288

  28. [36]

    U., Lam, N

    Neumann, A. U., Lam, N. P., Dahari, H., Gretch, D. R., Wiley, T. E., Layden, T. J., and Perelson, A. S. (1998). Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-αTherapy.Science, 282:103–107

  29. [37]

    Perelson, A. S. (2002). Modelling viral and immune system dynamics.Nat. Rev. Immunol., 2:28–36

  30. [38]

    S., Essunger, P., Cao, Y ., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M., and Ho, D

    Perelson, A. S., Essunger, P., Cao, Y ., Vesanen, M., Hurley, A., Saksela, K., Markowitz, M., and Ho, D. D. (1997). Decay characteristics of HIV-1-infected compartments during combination therapy.Nature, 387:188–191. 20

  31. [39]

    Perelson, A. S. and Guedj, J. (2015). Modelling hepatitis C therapy–predicting effects of treatment.Nat. Rev. Gastroen- terol. Hepatol., 12:437–445

  32. [40]

    S., Neumann, A

    Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M., and Ho, D. D. (1996). HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time.Science, 271:1582–1586

  33. [41]

    Perthame, B. (2007). Transport Equations in Biology. Birkhäuser, Basel, Switzerland, doi:10.1007/978-3-7643-7842-4

  34. [42]

    Quintela, B. d. M., Conway, J. M., Hyman, J. M., Guedj, J., dos Santos, R. W., Lobosco, M., and Perelson, A. S. (2018). A New Age-Structured Multiscale Model of the Hepatitis C Virus Life-Cycle During Infection and Therapy With Direct-Acting Antiviral Agents.Front. Microbiol., 9:1–11

  35. [43]

    Reid, W. T. (1930). Properties of Solutions of an Infinite System of Ordinary Linear Differential Equations of the First Order with Auxiliary Boundary Conditions.Trans. Am. Math. Soc., 32:284–318

  36. [44]

    C., Dahari, H., and Perelson, A

    Reluga, T. C., Dahari, H., and Perelson, A. S. (2009). Analysis of Hepatitis C Virus Infection Models with Hepatocyte Homeostasis.SIAM J. Appl. Math., 69:999–1023

  37. [45]

    M., and Perelson, A

    Rong, L., Dahari, H., Ribeiro, R. M., and Perelson, A. S. (2010). Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus.Sci Transl Med., 2:1-7

  38. [46]

    J., Levi, M., Smith, P., and Perelson, A

    Rong, L., Guedj, J., Dahari, H., Coffield, D. J., Levi, M., Smith, P., and Perelson, A. S. (2013). Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model.PLOS Comput. Biol., 9:e1002959

  39. [47]

    and Perelson, A

    Rong, L. and Perelson, A. S. (2013). Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents.Math. Biosci., 245:22–30

  40. [48]

    M., and Sulkowski, M

    Sachithanandham, J., Balagopal, A., Leep-Lazar, J., Quinn, J., Bowden, K., Ward, K., Ribeiro, R. M., and Sulkowski, M. S. (2023). Second-Phase Hepatitis C Plasma Viral Kinetics Directly Reflects Reduced Intrahepatic Burden of Hepatitis C Virus.J. Infect. Dis., 228:311–320

  41. [49]

    S., Ribeiro, R

    Sanche, S., Cassidy, T., Chu, P., Perelson, A. S., Ribeiro, R. M., and Ke, R. (2022). A simple model of COVID-19 explains disease severity and the effect of treatments.Sci. Rep., 12:14210

  42. [50]

    N., Jorga, K., Goggin, T., Grippo, J., Jumbe, N

    Snoeck, E., Chanu, P., Lavielle, M., Jacqmin, P., Jonsson, E. N., Jorga, K., Goggin, T., Grippo, J., Jumbe, N. L., and Frey, N. (2010). A Comprehensive Hepatitis C Viral Kinetic Model Explaining Cure.Clin. Pharmacol. Ther., 87:706–713

  43. [51]

    D., Staver, A

    Touboul, J. D., Staver, A. C., and Levin, S. A. (2018). On the complex dynamics of savanna landscapes.Proc. Natl. Acad. Sci. U.S.A, 115:E1336–E1345

  44. [52]

    Wang, X., Ge, Q., Zhao, H., and Rong, L. (2024). Mathematical analysis of a multiscale hepatitis C virus infection model with two viral strains.Appl. Math. Model., 125:241–260

  45. [53]

    Webster, B., Wissing, S., Herker, E., Ott, M., and Greene, W. C. (2013). Rapid Intracellular Competition between Hepatitis C Viral Genomes as a Result of Mitosis.J. Virol., 87:581–596

  46. [54]

    Woot de Trixhe, X., Krzyzanski, W.,De Ridder, F., and Vermeulen, A. (2015). vRNA structured population model for Hepatitis C Virus dynamics.J. Theor. Biol., 378:1–11

  47. [55]

    Woot de Trixhe, X., Krzyzanski, W., Vermeulen, A., and Perez-Ruixo, J. J. (2021). Multiscale model of hepatitis C virus dynamics in plasma and liver following combination therapy.CPT Pharmacometrics Syst. Pharmacol., 10:826–838

  48. [56]

    Zitzmann, C., Kaderali, L., and Perelson, A. S. (2020). Mathematical modeling of hepatitis C RNA replication, exosome secretion and virus release.PLOS Comput. Biol., 16:e1008421. 21 A Generational tracking of infected hepatocytes Here, we prove that the infinite system of ODEs...

  49. [57]

    For simplicity, the antiviral effects of the NS5A inhibitor were assumed to be constant during treatment [21, 46]

    included three distinct antiviral effects of NS5A inhibitor treatment, namely decreasing the production rate of intracellular vRNA by a factor 1−εα, whereε α ∈[0,1]is the drug effect on the production of intracellular vRNA, increasing the degradation rate of intracellular vRNA...

Pith tools

Reviewed August 7, 2026 · model on record in the stance chip above.